170 related articles for article (PubMed ID: 18954439)
21. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
22. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
[TBL] [Abstract][Full Text] [Related]
23. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14.
Filanti C; Dickson GR; Di Martino D; Ulivi V; Sanguineti C; Romano P; Palermo C; Manduca P
J Bone Miner Res; 2000 Nov; 15(11):2154-68. PubMed ID: 11092396
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C
Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993
[TBL] [Abstract][Full Text] [Related]
25. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
[TBL] [Abstract][Full Text] [Related]
26. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
[TBL] [Abstract][Full Text] [Related]
27. The imbalanced expression of matrix metalloproteinases in nephrogenic systemic fibrosis.
Kelly BC; Markle LS; Vickers JL; Petitt MS; Raimer SS; McNeese C
J Am Acad Dermatol; 2010 Sep; 63(3):483-9. PubMed ID: 20708474
[TBL] [Abstract][Full Text] [Related]
28. Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro.
Shimizu T; Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2005 Aug; 2005(3):150-9. PubMed ID: 16106101
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
Boveland SD; Moore PA; Mysore J; Krunkosky TM; Dietrich UM; Jarrett C; Paige Carmichael K
Vet Ophthalmol; 2010 Mar; 13(2):81-90. PubMed ID: 20447025
[TBL] [Abstract][Full Text] [Related]
30. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Baker EA; Bergin FG; Leaper DJ
Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
[TBL] [Abstract][Full Text] [Related]
32. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S
Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of remodeling markers by tissue structure in nasal polyposis.
de Borja Callejas F; Picado C; Martínez-Antón A; Alobid I; Pujols L; Valero A; Roca-Ferrer J; Mullol J
Am J Rhinol Allergy; 2013; 27(3):e69-74. PubMed ID: 23710947
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
[TBL] [Abstract][Full Text] [Related]
35. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
[TBL] [Abstract][Full Text] [Related]
38. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
[TBL] [Abstract][Full Text] [Related]
39. The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma.
Sakata K; Someya M; Omatsu M; Asanuma H; Hasegawa T; Ichimiya S; Hareyama M; Himi T
BMC Cancer; 2007 Dec; 7():229. PubMed ID: 18093334
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
